5 results
10-K
2020 FY
ASRT
Assertio Holdings Inc
12 Mar 21
Annual report
5:03pm
commercialization and development partners.
Impact of Public Pressure on Drug Pricing, Healthcare Reform and Legislation Impacting Payor Coverage … Schedule Program, and the Health Resources and Services Administration’s 340B Drug Pricing Program. We must also report specific prices to government
424B3
ASRT
Assertio Holdings Inc
20 Apr 20
Prospectus supplement
4:27pm
the continued focus of the U.S. Congress on drug pricing. Zyla's revenue and future profitability could be negatively affected if these inquiries were … -U.S. countries, prescription drug pricing and/or reimbursement is subject to governmental control. In those countries that impose price controls
S-4/A
ASRT
Assertio Holdings Inc
17 Apr 20
Registration of securities issued in business combination transactions (amended)
5:26pm
as well. While Zyla did not receive a letter, the letters and planned hearings demonstrate the continued focus of the U.S. Congress on drug pricing. Zyla's … strict price controls that may adversely affect Zyla's future profitability.
In most non-U.S. countries, prescription drug pricing
- Prev
- 1
- Next